Exclusive

Publication

Byline

BJP plotting to delete names of bona fide citizens from poll list: Abhishek

Kolkata, March 26 -- Trinamool Congress leader Abhishek Banerjee on Thursday accused the BJP government at the Centre of conspiring against the country's bona fide citizens by deleting their names fro... Read More


BSEB Bihar Board 10th Result 2026 OUT Soon: Check Expected Date, Scores Online & Download Marksheet via DigiLocker & BSEB Portal; Here's Official Direct Link at interbiharboard.com, bsebexam.com

India, March 26 -- Bihar State Board Class 10th Results 2026: The Bihar School Examination Board (BSEB) is set to announce the Class 10 results for 2026. Students who appeared for the board exams are ... Read More


Two Bengal tiger cubs at Bandung Zoo die of panleukopenia

Bandung, West Java, March 26 -- Two eight-month-old Bengal tiger cubs, Huru and Hara, at Bandung Zoo died from panleukopenia, according to the West Java Natural Resources Conservation Agency (BBKSDA).... Read More


कर्क राशिफल 27 मार्च 2026: करियर में नए अवसर मिलेंगे, कर्ज चुकाने में होंगे सफल, पार्टनर की फीलिंग का रखें ध्यान

नई दिल्ली, मार्च 26 -- Today Cancer Horoscope Aaj ka Kark Rashifal 27 March 2026, कर्क राशिफल 27 मार्च 2026: कर्क राशि वालों के लिए आज का दिन काफी शुभ साबित होता है। लेकिन कुछ चीजों को ध्यान में रखना ... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More


Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More


Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and... Read More